Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 14559 | 660 | 0.7276 | 0.7489 | 0.0453 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16059 | 813 | 0.7981 | 0.7489 | 0.0506 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 19884 | 1032 | 0.9869 | 1.0000 | 0.0519 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20251 | 1109 | 1.0021 | 1.0000 | 0.0548 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 20360 | 1046 | 1.0111 | 1.0000 | 0.0514 | 0.0527 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 1135 | 66 | 0.8529 | 1.0000 | 0.0581 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 1504 | 69 | 1.1449 | 1.0000 | 0.0459 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 1315 | 59 | 1.0021 | 1.0000 | 0.0449 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1511 | 68 | 1.1513 | 1.3011 | 0.0450 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 1771 | 79 | 1.3500 | 1.3011 | 0.0446 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 1846 | 89 | 1.4019 | 1.3011 | 0.0482 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 1386 | 59 | 1.0588 | 0.8133 | 0.0426 | 0.0417 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 956 | 43 | 0.7285 | 0.8133 | 0.0450 | 0.0417 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 850 | 32 | 0.6527 | 0.8133 | 0.0376 | 0.0417 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1325 | 58 | 1.0109 | 0.8059 | 0.0438 | 0.0432 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1146 | 49 | 0.8753 | 0.8059 | 0.0428 | 0.0432 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 696 | 30 | 0.5314 | 0.8059 | 0.0431 | 0.0432 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 981 | 39 | 0.7516 | 0.7976 | 0.0398 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 1126 | 71 | 0.8418 | 0.7976 | 0.0631 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1047 | 45 | 0.7995 | 0.7976 | 0.0430 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1049 | 35 | 0.8090 | 0.9306 | 0.0334 | 0.0304 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1347 | 40 | 1.0428 | 0.9306 | 0.0297 | 0.0304 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1212 | 34 | 0.9399 | 0.9306 | 0.0281 | 0.0304 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 1024 | 31 | 0.7923 | 0.6896 | 0.0303 | 0.0319 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 984 | 41 | 0.7524 | 0.6896 | 0.0417 | 0.0319 |